| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroblastoma | 28 | 2024 | 374 | 3.610 |
Why?
|
| Osteonectin | 8 | 2016 | 22 | 2.760 |
Why?
|
| Neovascularization, Pathologic | 12 | 2011 | 353 | 1.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 13 | 2019 | 1197 | 0.770 |
Why?
|
| Extracellular Matrix | 3 | 2011 | 232 | 0.750 |
Why?
|
| Cell Proliferation | 12 | 2019 | 1578 | 0.710 |
Why?
|
| DNA Methylation | 11 | 2019 | 628 | 0.710 |
Why?
|
| Naphthyridines | 1 | 2019 | 53 | 0.660 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2011 | 311 | 0.640 |
Why?
|
| Cell-Free Nucleic Acids | 3 | 2024 | 71 | 0.600 |
Why?
|
| Serum Albumin, Bovine | 1 | 2016 | 45 | 0.590 |
Why?
|
| Palmitic Acid | 1 | 2016 | 26 | 0.580 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 196 | 0.530 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 1464 | 0.480 |
Why?
|
| Mice, Nude | 13 | 2018 | 790 | 0.460 |
Why?
|
| Cell Line, Tumor | 15 | 2019 | 2426 | 0.460 |
Why?
|
| Schwann Cells | 4 | 2009 | 34 | 0.440 |
Why?
|
| Molecular Chaperones | 1 | 2011 | 111 | 0.390 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 123 | 0.390 |
Why?
|
| Fibroblasts | 3 | 2011 | 729 | 0.390 |
Why?
|
| 5-Methylcytosine | 2 | 2024 | 112 | 0.390 |
Why?
|
| Cell Movement | 7 | 2016 | 758 | 0.370 |
Why?
|
| Mice | 17 | 2019 | 11352 | 0.360 |
Why?
|
| Pancreatic Ducts | 2 | 1999 | 26 | 0.360 |
Why?
|
| Membrane Proteins | 3 | 2000 | 1196 | 0.340 |
Why?
|
| Animals | 21 | 2019 | 26582 | 0.300 |
Why?
|
| Stromal Cells | 4 | 2009 | 143 | 0.300 |
Why?
|
| Promoter Regions, Genetic | 7 | 2012 | 937 | 0.260 |
Why?
|
| Pancreatic Neoplasms | 2 | 1999 | 645 | 0.240 |
Why?
|
| Nervous System Neoplasms | 1 | 2003 | 11 | 0.240 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2016 | 689 | 0.230 |
Why?
|
| Adenocarcinoma | 2 | 2001 | 1169 | 0.220 |
Why?
|
| Peptide Fragments | 1 | 2004 | 460 | 0.220 |
Why?
|
| Humans | 36 | 2024 | 86643 | 0.220 |
Why?
|
| Tumor Cells, Cultured | 6 | 2007 | 1041 | 0.210 |
Why?
|
| Molecular Sequence Data | 6 | 2009 | 3030 | 0.210 |
Why?
|
| Valproic Acid | 3 | 2012 | 24 | 0.210 |
Why?
|
| Heterografts | 2 | 2019 | 98 | 0.210 |
Why?
|
| Neoplasms, Second Primary | 1 | 2023 | 252 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2012 | 458 | 0.190 |
Why?
|
| Receptors, Androgen | 1 | 2001 | 113 | 0.190 |
Why?
|
| Apoptosis | 4 | 2019 | 1683 | 0.180 |
Why?
|
| Azacitidine | 4 | 2018 | 137 | 0.180 |
Why?
|
| Transfection | 5 | 2010 | 896 | 0.180 |
Why?
|
| NIH 3T3 Cells | 2 | 2011 | 105 | 0.170 |
Why?
|
| Epigenomics | 1 | 2019 | 100 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2018 | 49 | 0.170 |
Why?
|
| Antineoplastic Agents | 5 | 2012 | 2360 | 0.160 |
Why?
|
| Cell Differentiation | 4 | 2012 | 1458 | 0.160 |
Why?
|
| Amino Acid Sequence | 4 | 2009 | 2062 | 0.160 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 2 | 2018 | 55 | 0.150 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2016 | 63 | 0.140 |
Why?
|
| Prognosis | 6 | 2024 | 3679 | 0.140 |
Why?
|
| Tissue Fixation | 1 | 2016 | 40 | 0.140 |
Why?
|
| Zonula Occludens-2 Protein | 3 | 2000 | 11 | 0.140 |
Why?
|
| Paraffin Embedding | 1 | 2016 | 78 | 0.140 |
Why?
|
| Formaldehyde | 1 | 2016 | 52 | 0.140 |
Why?
|
| Cell Hypoxia | 1 | 2016 | 164 | 0.140 |
Why?
|
| Epigenesis, Genetic | 5 | 2013 | 479 | 0.140 |
Why?
|
| Disease Progression | 2 | 2010 | 1531 | 0.130 |
Why?
|
| Genetic Therapy | 1 | 2016 | 342 | 0.120 |
Why?
|
| Neoplasms | 1 | 2009 | 2898 | 0.120 |
Why?
|
| Cell Survival | 1 | 2016 | 969 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2007 | 279 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2018 | 534 | 0.120 |
Why?
|
| Histocompatibility Antigens | 1 | 2013 | 35 | 0.120 |
Why?
|
| Female | 15 | 2019 | 44532 | 0.110 |
Why?
|
| Endothelial Cells | 3 | 2010 | 428 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2010 | 316 | 0.110 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 154 | 0.110 |
Why?
|
| Caspase 8 | 2 | 2013 | 34 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 2 | 2011 | 425 | 0.110 |
Why?
|
| Infant | 6 | 2019 | 3046 | 0.100 |
Why?
|
| Intracellular Space | 1 | 2011 | 38 | 0.100 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 55 | 0.100 |
Why?
|
| Benzenesulfonates | 1 | 2011 | 66 | 0.100 |
Why?
|
| Endothelium, Vascular | 2 | 2004 | 435 | 0.100 |
Why?
|
| Hypoxia | 1 | 2016 | 641 | 0.100 |
Why?
|
| Extracellular Space | 1 | 2011 | 90 | 0.100 |
Why?
|
| Genomics | 1 | 2016 | 720 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 192 | 0.100 |
Why?
|
| Quinoxalines | 1 | 2011 | 50 | 0.100 |
Why?
|
| Histones | 3 | 2024 | 311 | 0.090 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2007 | 57 | 0.090 |
Why?
|
| Protein Transport | 1 | 2011 | 411 | 0.090 |
Why?
|
| Collagen | 1 | 2011 | 269 | 0.090 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2009 | 11 | 0.090 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2009 | 13 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2009 | 21 | 0.090 |
Why?
|
| Gene Silencing | 3 | 2004 | 172 | 0.090 |
Why?
|
| Thrombospondins | 1 | 2009 | 14 | 0.090 |
Why?
|
| Pyridines | 1 | 2011 | 310 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 1721 | 0.090 |
Why?
|
| Models, Biological | 1 | 2016 | 1749 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2011 | 615 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2012 | 157 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2001 | 879 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2009 | 73 | 0.090 |
Why?
|
| Sequence Alignment | 1 | 2009 | 351 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 179 | 0.080 |
Why?
|
| Thrombospondin 1 | 2 | 2010 | 21 | 0.080 |
Why?
|
| Neoplasm Metastasis | 3 | 2019 | 1056 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2003 | 1135 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 286 | 0.080 |
Why?
|
| Tumor Necrosis Factor Decoy Receptors | 1 | 2007 | 4 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 589 | 0.080 |
Why?
|
| Transplantation, Heterologous | 2 | 2006 | 363 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2016 | 860 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2009 | 427 | 0.070 |
Why?
|
| Base Sequence | 3 | 1999 | 2330 | 0.070 |
Why?
|
| Neoplasm Transplantation | 4 | 2011 | 391 | 0.070 |
Why?
|
| Cell Division | 3 | 2003 | 696 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2011 | 1924 | 0.070 |
Why?
|
| Peptides | 1 | 2010 | 639 | 0.070 |
Why?
|
| Calcium | 1 | 2011 | 1156 | 0.070 |
Why?
|
| Child | 4 | 2023 | 6927 | 0.070 |
Why?
|
| Methylation | 1 | 2007 | 251 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2818 | 0.070 |
Why?
|
| Blotting, Western | 3 | 2009 | 782 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 2232 | 0.070 |
Why?
|
| Oligopeptides | 1 | 2007 | 179 | 0.070 |
Why?
|
| Male | 9 | 2019 | 40965 | 0.070 |
Why?
|
| Infant, Newborn | 3 | 2019 | 2379 | 0.060 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 119 | 0.060 |
Why?
|
| DNA, Neoplasm | 2 | 2004 | 265 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2004 | 210 | 0.060 |
Why?
|
| Cell Cycle | 3 | 2011 | 502 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2007 | 1753 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2004 | 179 | 0.060 |
Why?
|
| Cytokines | 1 | 2007 | 776 | 0.060 |
Why?
|
| Introns | 2 | 2000 | 289 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 736 | 0.050 |
Why?
|
| Protein Folding | 1 | 2004 | 282 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2009 | 3241 | 0.050 |
Why?
|
| Exons | 2 | 2000 | 450 | 0.050 |
Why?
|
| Prostaglandin D2 | 1 | 2001 | 27 | 0.050 |
Why?
|
| Acetylation | 2 | 2012 | 121 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 532 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2012 | 85 | 0.050 |
Why?
|
| Urothelium | 1 | 2001 | 70 | 0.050 |
Why?
|
| Thiazolidinediones | 1 | 2001 | 82 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2019 | 3612 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 122 | 0.050 |
Why?
|
| Androgens | 1 | 2001 | 167 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2006 | 621 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1999 | 54 | 0.050 |
Why?
|
| Kidney | 1 | 2006 | 1241 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2000 | 270 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 1384 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2001 | 526 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 1999 | 115 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 1999 | 256 | 0.040 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2018 | 18 | 0.040 |
Why?
|
| Multigene Family | 1 | 1999 | 202 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 1999 | 132 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 106 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2013 | 639 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 151 | 0.040 |
Why?
|
| Cricetinae | 1 | 1999 | 560 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 236 | 0.040 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 102 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2004 | 1565 | 0.040 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2001 | 383 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1313 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2001 | 1981 | 0.040 |
Why?
|
| Databases, Nucleic Acid | 1 | 2016 | 41 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 2438 | 0.040 |
Why?
|
| Neurons | 1 | 2005 | 1546 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 927 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 387 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 859 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2014 | 2767 | 0.030 |
Why?
|
| Adult | 3 | 2019 | 25648 | 0.030 |
Why?
|
| Azepines | 1 | 2013 | 20 | 0.030 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2013 | 36 | 0.030 |
Why?
|
| Computational Biology | 1 | 2016 | 528 | 0.030 |
Why?
|
| Adolescent | 2 | 2019 | 8981 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2013 | 83 | 0.030 |
Why?
|
| Gene Expression | 2 | 2012 | 1284 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 2013 | 59 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 1204 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2013 | 159 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2014 | 369 | 0.030 |
Why?
|
| G1 Phase | 1 | 2012 | 63 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2012 | 63 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2013 | 295 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 63 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 1961 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 736 | 0.030 |
Why?
|
| Transcriptome | 1 | 2016 | 580 | 0.030 |
Why?
|
| Tretinoin | 1 | 2012 | 126 | 0.030 |
Why?
|
| Quinazolines | 1 | 2013 | 220 | 0.030 |
Why?
|
| Niacinamide | 1 | 2011 | 116 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2012 | 271 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 1939 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2011 | 114 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 938 | 0.020 |
Why?
|
| DNA Modification Methylases | 1 | 2010 | 25 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2705 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 293 | 0.020 |
Why?
|
| Cell Shape | 1 | 2010 | 51 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 133 | 0.020 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Pericytes | 1 | 2009 | 12 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2009 | 33 | 0.020 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2009 | 20 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2012 | 592 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 696 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 5976 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2007 | 124 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2007 | 83 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2011 | 7993 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 2007 | 130 | 0.020 |
Why?
|
| Actins | 1 | 2009 | 451 | 0.020 |
Why?
|
| GAP-43 Protein | 1 | 2005 | 2 | 0.020 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2005 | 6 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 1851 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2007 | 504 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2005 | 44 | 0.020 |
Why?
|
| Ganglioneuroma | 1 | 2004 | 9 | 0.020 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2004 | 25 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 64 | 0.020 |
Why?
|
| S100 Proteins | 1 | 2005 | 50 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 121 | 0.020 |
Why?
|
| HSP47 Heat-Shock Proteins | 1 | 2004 | 1 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2004 | 54 | 0.020 |
Why?
|
| Collagen Type IV | 1 | 2004 | 24 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2004 | 62 | 0.020 |
Why?
|
| Phenotype | 1 | 2010 | 2378 | 0.010 |
Why?
|
| HLA Antigens | 1 | 2005 | 232 | 0.010 |
Why?
|
| CpG Islands | 1 | 2003 | 151 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2004 | 236 | 0.010 |
Why?
|
| Biomarkers | 1 | 2009 | 1718 | 0.010 |
Why?
|
| Chromans | 1 | 2001 | 30 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 712 | 0.010 |
Why?
|
| Thiazoles | 1 | 2001 | 131 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 1863 | 0.010 |
Why?
|
| Dinucleotide Repeats | 1 | 1999 | 13 | 0.010 |
Why?
|
| Ligands | 1 | 2001 | 433 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2001 | 170 | 0.010 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 1999 | 41 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1999 | 393 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 543 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 636 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1999 | 201 | 0.010 |
Why?
|
| Cell Line | 1 | 2001 | 2468 | 0.010 |
Why?
|
| Alleles | 1 | 1999 | 1128 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 1999 | 819 | 0.010 |
Why?
|
| Aged | 1 | 2001 | 18415 | 0.000 |
Why?
|